Literature DB >> 9176536

Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome.

L Armstrong1, A B Millar.   

Abstract

BACKGROUND: The adult respiratory distress syndrome (ARDS) may be regarded as an example of an uncontrolled or excessive inflammatory response in which tumour necrosis factor alpha (TNF-alpha) has been proposed to play a central role. Interleukin 10 (IL-10) has been identified as an important regulator of this response. The potential role for IL-10 in this context was investigated by measuring the relative production of IL-10 and TNF-alpha protein in the plasma, bronchoalveolar lavage (BAL) fluid, and alveolar macrophage culture supernatants of patients with, or at risk of developing, ARDS.
METHODS: Twenty six patients were studied from three groups at risk of or with ARDS: sepsis (n = 12), multiple trauma (n = 8), and perforated bowel (n = 6). Ten patients had ARDS. Bronchoalveolar lavage and venepuncture were performed within 24 hours of arrival on the intensive therapy unit or of diagnosis of ARDS. IL-10 and TNF-alpha protein were detected in the plasma, BAL fluid, and alveolar macrophage supernatants by sandwich enzyme linked immunoabsorbent assays.
RESULTS: The median IL-10 concentrations in the plasma and BAL fluid of patients with ARDS were significantly lower than the concentrations detectable in the plasma (median difference-17.5, 95% CI -52.4 to 1.31, p < 0.05) and BAL fluid of at risk patients (median difference -32.1, 95% CI -47.5 to 2.3, p < 0.05). There was a tendency towards enhanced concentrations of TNF-alpha detectable in the alveolar macrophage supernatants and the BAL fluid of patients with ARDS compared with at risk patients, although this did not reach statistical significance. No difference was observed in the plasma concentrations of TNF-alpha between the two groups. The ratios of TNF-alpha to IL-10 protein in the BAL fluid of patients with ARDS and at risk patients were 3.52 and 0.85, respectively (median difference 1.44, 95% CI 0.07 to 5.01, p < 0.01). There was no difference in alveolar macrophage production of IL-10 between the two groups.
CONCLUSIONS: This study highlights the potential importance of the pro-inflammatory versus the anti-inflammatory imbalance in ARDS which may be reflected by the ratio of IL-10 and TNF-alpha in the lung.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176536      PMCID: PMC1758565          DOI: 10.1136/thx.52.5.442

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  23 in total

1.  Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy.

Authors:  P C Pratt; R T Vollmer; J D Shelburne; J D Crapo
Journal:  Am J Pathol       Date:  1979-04       Impact factor: 4.307

2.  Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.

Authors:  C Wanidworanun; W Strober
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

Review 3.  Adult respiratory-distress syndrome: changing concepts of lung injury and repair.

Authors:  J E Rinaldo; R M Rogers
Journal:  N Engl J Med       Date:  1982-04-15       Impact factor: 91.245

4.  Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes.

Authors:  L Armstrong; N Jordan; A Millar
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

5.  Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis.

Authors:  T L Bonfield; M W Konstan; P Burfeind; J R Panuska; J B Hilliard; M Berger
Journal:  Am J Respir Cell Mol Biol       Date:  1995-09       Impact factor: 6.914

6.  Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality.

Authors:  E J Miller; A B Cohen; S Nagao; D Griffith; R J Maunder; T R Martin; J P Weiner-Kronish; M Sticherling; E Christophers; M A Matthay
Journal:  Am Rev Respir Dis       Date:  1992-08

7.  Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.

Authors:  D A Joyce; D P Gibbons; P Green; J H Steer; M Feldmann; F M Brennan
Journal:  Eur J Immunol       Date:  1994-11       Impact factor: 5.532

8.  Interleukin-10 production during septicaemia.

Authors:  A Marchant; J Devière; B Byl; D De Groote; J L Vincent; M Goldman
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

9.  Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide.

Authors:  M A Cassatella; L Meda; S Bonora; M Ceska; G Constantin
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  Immunoregulatory role of interleukin 10 in rheumatoid arthritis.

Authors:  P D Katsikis; C Q Chu; F M Brennan; R N Maini; M Feldmann
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  45 in total

Review 1.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

2.  A clinically applicable porcine model of septic and ischemia/reperfusion-induced shock and multiple organ injury.

Authors:  Brian D Kubiak; Scott P Albert; Louis A Gatto; Christopher J Vieau; Shreyas K Roy; Kathleen P Snyder; Kristopher G Maier; Gary F Nieman
Journal:  J Surg Res       Date:  2010-11-12       Impact factor: 2.192

3.  Proinflammatory cytokine surge after injury stimulates an airway immunoglobulin a increase.

Authors:  Mark A Jonker; Yoshifumi Sano; Joshua L Hermsen; Jinggang Lan; Kenneth A Kudsk
Journal:  J Trauma       Date:  2010-10

4.  IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?

Authors:  A B Millar
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

5.  Interleukin-10 gene transfer: prevention of multiple organ injury in a murine cecal ligation and puncture model of sepsis.

Authors:  Burhan Kabay; Cetin Kocaefe; Atac Baykal; Hilmi Ozden; Cengiz Baycu; Zafer Oner; Meral Ozgüç; Iskender Sayek
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

6.  Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome.

Authors:  M N Gong; B T Thompson; P L Williams; W Zhou; M Z Wang; L Pothier; D C Christiani
Journal:  Eur Respir J       Date:  2006-04       Impact factor: 16.671

7.  Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis.

Authors:  L Armstrong; A R L Medford; K J Hunter; K M Uppington; A B Millar
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

8.  Hemorrhagic shock augments Nlrp3 inflammasome activation in the lung through impaired pyrin induction.

Authors:  Peng Xu; Zongmei Wen; Xueyin Shi; Yuehua Li; Liyan Fan; Meng Xiang; Aijun Li; Melanie J Scott; Guozhi Xiao; Song Li; Timothy R Billiar; Mark A Wilson; Jie Fan
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

Review 9.  Genetic epidemiology of acute respiratory distress syndrome: implications for future prevention and treatment.

Authors:  Michelle Ng Gong
Journal:  Clin Chest Med       Date:  2006-12       Impact factor: 2.878

10.  Gene expression profiles characterize inflammation stages in the acute lung injury in mice.

Authors:  Isabelle Lesur; Julien Textoris; Béatrice Loriod; Cécile Courbon; Stéphane Garcia; Marc Leone; Catherine Nguyen
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.